RxDoctor Payments Data

Max Quintana, MD

Family Medicine · Houston, TXNPI 1538392345

Payments from drug & device makers

$2,978in general payments, 2019–2025

Across 175 payments — averaging $17.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$585
  • Abbott$498
  • Lilly USA, LLC$407
  • AbbVie$291
  • Amgen$278
  • Exact Sciences$216
  • plus $703 from 15 others

What the payments were for

  • Food & beverage$2,964100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,978 in reported general payments places this provider in the 75th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$63,372
Medicare patients
166
Services billed
672

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin40$56,739
OzempicSemaglutide49$45,909
EliquisApixaban32$36,799
TrulicityDulaglutide21$27,606
JanuviaSitagliptin Phosphate14$16,486
MounjaroTirzepatide14$15,459
JanumetSitagliptin Phos/Metformin Hcl17$13,832
VascepaIcosapent Ethyl17$7,189
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog15$6,886
Tresiba Flextouch U-100Insulin Degludec17$5,492
Atorvastatin Calcium307$1,704
SynthroidLevothyroxine Sodium22$1,558
Gabapentin89$1,539
Levothyroxine Sodium162$1,485
Losartan Potassium121$1,431

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$112$56,73940 claims
Novo NordiskOzempic$585$45,90949 claims
Lilly USA, LLCTrulicity, Mounjaro, Humulin 70-30$407$43,53946 claims
PfizerEliquis$50$36,79932 claims
MerckJanuvia, Janumet$27$30,31931 claims
AbbVieSynthroid$291$1,55822 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →